Leadership & Pay ·
MeiraGTx appoints Alan M. Sebulsky to its Board of Directors
MGTXMeiraGTx Holdings plc
MeiraGTx Holdings plc appointed Alan M. Sebulsky to its Board of Directors as a Class I director, effective September 23, 2026. Mr. Sebulsky will serve on the Science and Technology Committee and is eligible for compensation under the Company’s Non-Employee Director Compensation Program. He brings over 40 years of experience in healthcare investment, most recently serving as Managing Member of Apothecary Capital LLC and previously as a Partner at Adage Capital Management. MeiraGTx Holdings plc operates as a vertically integrated, clinical-stage genetic medicines company developing viral vector therapies for inherited and common diseases.